No Data
Shanghai Xuerong Bio-Technology (300511.SZ) has issued a profit warning, estimating an annual net loss of between 0.435 billion yuan and 0.65 billion yuan.
Shanghai Xuerong Bio-Technology (300511.SZ) disclosed its performance forecast for 2024, expecting to belong to the listed company's Shareholders...
Xuerong Biology: Shanghai Xuerong Biotechnology Co., Ltd. 2024 Annual Performance Forecast
Investors Don't See Light At End Of Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Tunnel And Push Stock Down 26%
Further Weakness as Shanghai Xuerong BiotechnologyLtd (SZSE:300511) Drops 16% This Week, Taking Three-year Losses to 47%
shanghai xuerong bio-technology (300511.SZ): It is planned to extend the "annual output of 0.12 million tons of edible fungi modern agriculture industrial park project" to December 31, 2026.
Shanghai Xuerong Bio-Technology (300511.SZ) announced that on November 29, 2024, the company held the 18th meeting of the fifth board of directors and the 11th meeting of the fifth board of supervisors, deliberating and passing the resolution on the extension of the date for the 'Annual output of 0.12 million tons of edible fungus modern agriculture industrial park project' to reach the designated available state until December 31, 2026. This proposal does not involve changes in the use of funds raised and does not require approval by the company's shareholders' meeting.
Xuerong Biology: Report for the third quarter of 2024
Revenues Working Against Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Share Price Following 26% Dive